(Euronext Amsterdam:INGA),(Brussels:INGA), Progress on share buyback programme ING announced today that, as part of our EUR1.1 billion share buyback programme announced on 30 October 2025, in total 2,528,615 shares were repurchased during the week of 23 February up to and including 27 February 2026. The shares were repurchased at an average price of EUR24.86 for […]

WARRINGTON, United Kingdom, March 03, 2026 (GLOBE NEWSWIRE) — At Mobile World Congress in Barcelona from 2 to 5 March, Jersey Telecom, MVNE Pty Ltd, MDS Global and Ycorp will announce the formation of a new global consortium. The collaboration is designed to reshape how Mobile Virtual Network Operators launch, scale and expand across international

Progress on share buyback programme GlobeNewswire March 03, 2026 Progress on share buyback programme ING announced today that, as part of our EUR1.1 billion share buyback programme announced on 30 October 2025, in total 2,528,615 shares were repurchased during the week of 23 February up to and including 27 February 2026. The shares were repurchased

A New Global MVNO Consortium Launches at MWC to Simplify International Expansion GlobeNewswire March 03, 2026 WARRINGTON, United Kingdom, March 03, 2026 (GLOBE NEWSWIRE) — At Mobile World Congress in Barcelona from 2 to 5 March, Jersey Telecom, MVNE Pty Ltd, MDS Global and Ycorp will announce the formation of a new global consortium. The

SNIPR announces Publication of Final Positive Phase 1 Results for SNIPR001 in The Lancet Microbe GlobeNewswire March 03, 2026 First-ever randomized, placebo-controlled Phase 1 trial – published in The Lancet Microbe – supports SNIPR001's safety, tolerability, and restriction to the gastrointestinal tract in healthy participants Oral SNIPR001 was well tolerated across three dose levels and

DUBAI, United Arab Emirates, March 03, 2026 (GLOBE NEWSWIRE) — AEON Clinic, a top pioneer in regenerative medicine and opulent healthcare situated at Atlantis the Royal, is happy to present EXOMIND(TM), an innovative, non-invasive Transcranial Magnetic Stimulation (TMS) system. Intended to transform mental well-being, EXOMIND(TM) provides a science-led OCD treatment, Anxiety treatment, drug-free alternative for

AEON Clinic Introduces Exomind to Treat OCD ADHD PTSD And Other Complex Mental Health Conditions The Future of Mental Sovereignty: AEON Clinic Launch EXOMIND(TM) at Atlantis The Royal GlobeNewswire March 03, 2026 DUBAI, United Arab Emirates, March 03, 2026 (GLOBE NEWSWIRE) — AEON Clinic, a top pioneer in regenerative medicine and opulent healthcare situated at

Barcelona, March 03, 2026 (GLOBE NEWSWIRE) — At MWC Barcelona 2026, iFLYTEK presented its end-to-end AI ecosystem under the theme “AI CONNECTING IDEAS”. As a leading AI company in intelligent speech and AI technologies, iFLYTEK demonstrated how AI can be securely deployed, locally adapted, and practically embedded across public services, enterprises, and professional workflows. This

iFLYTEK Showcases Secure AI Infrastructure, Enterprise Solutions, and Multilingual Intelligence at MWC Barcelona 2026 Delivering trusted, deployable AI that connects public services, organizations, and individuals. GlobeNewswire March 03, 2026 Barcelona, March 03, 2026 (GLOBE NEWSWIRE) — At MWC Barcelona 2026, iFLYTEK presented its end-to-end AI ecosystem under the theme “AI CONNECTING IDEAS”. As a leading

(NASDAQ:HTO), SAN JOSE, Calif., March 03, 2026 (GLOBE NEWSWIRE) — H2O America (NASDAQ: HTO) (“HTO” or the “Company”) announced today that it has priced its previously announced underwritten public offering of 11,484,824 shares of its common stock, par value $0.001 per share, at a public offering price of $53.00 per share (the “Offering”). The total